Received Aug 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y019318 | — |
HCP reporting that a patient received a dose of improperly stored VARIVAX; No additional AE; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, current conditions and concomitant therapies was not reported. On 16-JUL-2025, the patient received a dose of improperly stored with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) at a dose of 0.5ml (lot #Y019318, who had been verified to be a valid lot number, expiration date reported and validated as 21-NOV-2026) as prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT). The vaccine temperature was 52.2F, and there was no information about the date the excursion occurred (Product storage error). There was no information about previous temperature excursion. No additional adverse events.
Sterile diluent